Found 1221 matching trials
Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE1 RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Show More Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Learn More & Join Trial
Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) PHASE3 Neutropenia, a condition characterized by an abnormally low number of infec...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Lund University Hospital
Learn More & Join Trial
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Show More Status
Active Not Recruiting
Location
Regional Medical Center
Learn More & Join Trial
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma PHASE2 RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Show More Location
Knight Cancer Institute at Oregon Health and Science University
Learn More & Join Trial
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma EARLY_PHASE1 The purpose of this study is to determine if the combination of G-CSF and b...
Show More Location
University of Kansas Medical Center
Learn More & Join Trial
A Study of LY2523355 in Participants With Breast Cancer PHASE2 The purpose of the study is to evaluate the anti-tumor activity of LY252335...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer PHASE1 This phase I clinical trial evaluates the safety and feasibility of adminis...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Tulane Cancer Center at Tulane University Hospital and Clinic
Learn More & Join Trial
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
New England Medical Center Hospital
Learn More & Join Trial